The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Seidman, S. N.
* Articles by Rosen, R. C.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Seidman, S. N.
* Articles by Rosen, R. C.
Related Collections
* Miscellaneous Mood Disorders
* Sexual Disorders
* Miscellaneous Somatic Therapies
Am J Psychiatry 158:1623-1630, October 2001
© 2001 American Psychiatric Association


Article

Treatment of Erectile Dysfunction in Men With Depressive Symptoms: Results of a Placebo-Controlled Trial With Sildenafil Citrate

Stuart N. Seidman, M.D., Steven P. Roose, M.D., Matthew A. Menza, M.D., Ridwan Shabsigh, M.D., and Raymond C. Rosen, Ph.D.

OBJECTIVE: Depressed men commonly have erectile dysfunction, and men with erectile dysfunction are frequently depressed. Since the etiologic and modulatory relationships between depression and erectile dysfunction have been poorly characterized, a 12-week, randomized, double-blind, placebo-controlled trial was conducted at 20 urologic clinics to evaluate the effects of sildenafil treatment in men with erectile dysfunction and mild-to-moderate comorbid depressive illness. METHOD: Men (N=152, mean age=56 years) with erectile dysfunction for >=6 months (mean=5.7 years), a DSM-IV diagnosis of depressive disorder not otherwise specified, and a Hamilton Depression Rating Scale score >=12 (mean at baseline=16.9) were randomly assigned to flexible-dose treatment with sildenafil citrate or matching placebo. Interviewer-rated and self-report instruments were used to assess changes in sexual function, depressive symptoms, and quality of life. Conservative criteria were used to classify erectile dysfunction treatment response and nonresponse. RESULTS: Sildenafil was strongly associated with erectile dysfunction treatment response. Fifty-eight men met the conservative criteria for response (48 given sildenafil, 10 given placebo), and 78 men did not respond (18 given sildenafil, 60 given placebo). Mean decreases of 10.6 and 2.3 in Hamilton depression scale scores were seen  in treatment responders and nonresponders, respectively; 76% of treatment responders showed a >=50% decline in Hamilton depression scale score versus 14% of nonresponders. Quality of life was similarly improved in treatment responders. CONCLUSIONS: Sildenafil is efficacious for erectile dysfunction in men with mild-to-moderate depressive illness. Improvement of erectile dysfunction is associated with marked improvement in depressive symptoms and quality of life.




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
A. Qaseem, V. Snow, T. D. Denberg, D. E. Casey Jr., M. A. Forciea, D. K. Owens, P. Shekelle, and for the Clinical Efficacy Assessment Subcommittee
Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Ann Intern Med, November 3, 2009; 151(9): 639 - 649.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. Tsertsvadze, H. A. Fink, F. Yazdi, R. MacDonald, A. J. Bella, M. T. Ansari, C. Garritty, K. Soares-Weiser, R. Daniel, M. Sampson, et al.
Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis
Ann Intern Med, November 3, 2009; 151(9): 650 - 661.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
A. Tsertsvadze, H. A. Fink, F. Yazdi, R. MacDonald, A. J. Bella, M. T. Ansari, C. Garritty, K. Soares-Weiser, R. Daniel, M. Sampson, et al.
Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis
Ann Intern Med, October 19, 2009; (2009) 0000605-200911030-00150v1.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
A. Qaseem, V. Snow, T. D. Denberg, D. E. Casey Jr., M. A. Forciea, D. K. Owens, P. Shekelle, and for the Clinical Efficacy Assessment Subcommittee
Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Ann Intern Med, October 19, 2009; (2009) 0000605-200911030-00151v1.
[Abstract] [Full Text]


Home page
Alcohol AlcoholHome page
A. Grinshpoon, A. Margolis, A. Weizman, and A. M. Ponizovsky
Sildenafil citrate in the treatment of sexual dysfunction and its effect on quality of life in alcohol dependent men: preliminary findings
Alcohol Alcohol., July 1, 2007; 42(4): 340 - 346.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
Y.-S. Peng, C.-K. Chiang, K.-Y. Hung, S.-S. Chiang, C.-S. Lu, C.-S. Yang, K.-D. Wu, C.-C. Yang, R.-P. Lin, C.-J. Chang, et al.
The association of higher depressive symptoms and sexual dysfunction in male haemodialysis patients
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 857 - 861.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Ment. HealthHome page
B. R Underwood
Vardenafil improves comorbid erectile dysfunction and mild depression.
Evid. Based Ment. Health, August 1, 2006; 9(3): 77 - 77.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
R. Rosen, R. Shabsigh, M. Berber, P. Assalian, M. Menza, L. Rodriguez-Vela, R. Porto, K. Bangerter, M. Seger, F. Montorsi, et al.
Efficacy and Tolerability of Vardenafil in Men With Mild Depression and Erectile Dysfunction: The Depression-Related Improvement With Vardenafil for Erectile Response Study
Am J Psychiatry, January 1, 2006; 163(1): 79 - 87.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
C. C. Carson
Erectile Dysfunction: Evaluation and New Treatment Options
Psychosom Med, September 1, 2004; 66(5): 664 - 671.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
L. J. Webster, E. D. Michelakis, T. Davis, and S. L. Archer
Use of Sildenafil for Safe Improvement of Erectile Function and Quality of Life in Men With New York Heart Association Classes II and III Congestive Heart Failure: A Prospective, Placebo-Controlled, Double-blind Crossover Trial
Arch Intern Med, March 8, 2004; 164(5): 514 - 520.
[Abstract] [Full Text] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
D. Baldwin and A. Mayers
Sexual side-effects of antidepressant and antipsychotic drugs
Adv. Psychiatr. Treat., May 1, 2003; 9(3): 202 - 210.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. G. Nurnberg, P. L. Hensley, A. J. Gelenberg, M. Fava, J. Lauriello, and S. Paine
Treatment of Antidepressant-Associated Sexual Dysfunction With Sildenafil: A Randomized Controlled Trial
JAMA, January 1, 2003; 289(1): 56 - 64.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. K. Schneider and J. L. Levenson
Update in Psychiatry
Ann Intern Med, October 15, 2002; 137(8): 671 - 677.
[Full Text] [PDF]


Home page
Evid. Based Med.Home page
S. A Wilson
Sildenafil improved erectile dysfunction and quality of life in men with comorbid mild to moderate depression
Evid. Based Med., July 1, 2002; 7(4): 121 - 121.
[Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
G. Hackett
Schedule 11 -- impact on treating erectile dysfunction
The British Journal of Diabetes & Vascular Disease, July 1, 2002; 2(4): 315 - 318.
[Abstract] [PDF]


Home page
JWatch PsychiatryHome page
Does Sildenafil Help Antidepressant-Induced Erectile Dysfunction? Does It Also Raise Mood?
Journal Watch Psychiatry, November 15, 2001; 2001(1115): 1 - 1.
[Full Text]


Home page
JAMAHome page
S. P. Roose, A. H. Glassman, and S. N. Seidman
Relationship Between Depression and Other Medical Illnesses
JAMA, October 10, 2001; 286(14): 1687 - 1690.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2001 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org